Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy

Martin Loessner 1Dr. Martin Loessner, ETH Zurich, Switzerland, will share his latest research during Targeting Microbiota 2024 this October.

"Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy"

Phage therapy of the future will not be what it used to be. Existing hurdles such as limited efficacy and rapid emergence of resistance can be overcome by genetic engineering of bacteriophages. Dr. Loessner will discuss how synthetic biology enables a completely new and highly specific approach to specifically target bacterial pathogens and re-balance the microbiome.

About Dr. Loessner

Martin J. Loessner is Full Professor of Food Microbiology at the Institute of Food, Nutrition and Health of ETH Zurich, Switzerland, since 2003. The research work in Martin Loessner-​s group is focussed on foodborne pathogens and their specific bacteriophages. Basic molecular biology research is used to derive novel and innovative applications for the detection and control of unwanted bacteria such as Listeria monocytogenes, Staphylococcus aureus, and others. Recombinant proteins are designed for labeling and immobilization of bacterial cells; and genetic engineering is used as a tool for improvement of cultures towards safer food products. This work has received several awards and prizes. The group is closely collaborating with a number of research groups, and has fruitful contacts with partners from the diagnostic and food industry.

Targeting Microbiota 2024 Speakers Line-up.

International Society of Microbiota
Targeting Microbiota 2024 Conference
October 14-15, 2024 - Malta
Press Releases | Newsletters Archive | LinkedIn 

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next